Sentences with phrase «by biotechnology companies»

Several of his protein engineered products are sold by biotechnology companies, including Avastin for treating cancers and Somavert for treating the growth hormone disorder acromegaly.

Roughly three - quarters of respondents work in private industry, with 47 percent employed by biotechnology companies, 33 percent in pharmas, and the remaining 20 percent in biopharmas.

Wilmut's work is supported by a biotechnology company, PPL Therapeutics in Edinburgh, which plans to use the patented cloning technique to produce animals that will secrete valuable drugs in their milk.

Not exact matches

WA - based biotechnology company Imugene Ltd has won exclusive distribution rights for its porcine adenoviral vector delivery system, after success in a hearing administered by the US patent office.

Jerusalem - based biotechnology lab - grown meat company Future Meat Technologies has announced a $ 2.2 million seed investment round co-led by Tyson Ventures, the venture capital arm of Tyson Foods.

COPENHAGEN, April 10 Genmab plans to own a bigger share of drugs in its early - stage pipeline as Europe's biggest biotechnology company prepares to reduce its reliance on a blockbuster cancer drug, marketed by partner Johnson & Johnson.

Bala Cynwyd, PA — January 31, 2017 — Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $ 22.6 million in Series A financing led by Deerfield Management and has appointed Carole Ben - Maimon, MD, as the company's president and chief executive officer.

George Budwell (iShares Nasdaq Biotechnology Index): Although the biotech industry is growing by leaps and bounds at the moment, the fact remains that individual companies — and even titans of the industry like Gilead Sciences — are fraught with clinical, regulatory, and commercial risk.

Syngenta arranged royalty - free access to the patents and intellectual property, held by several biotechnology companies, for a number of key technologies used in Golden Rice.

The «New York is losing» theme continued in Buffalo, where Astorino met reporters at ZeptoMetrix, a biotechnology company owned by Collins.

Environment minister Phil Woolas held talks with the Agricultural Biotechnology Council last night, a group which encourages the use of biotechnology in agriculture and spearheaded by controversial company Monsanto, one of the main GBiotechnology Council last night, a group which encourages the use of biotechnology in agriculture and spearheaded by controversial company Monsanto, one of the main Gbiotechnology in agriculture and spearheaded by controversial company Monsanto, one of the main GM businesses.

Although project «BioShield» was approved by a Senate committee last week, members of the House are voicing strong reservations about its potentially astronomical cost and negative impact on competition among biotechnology and pharmaceutical companies designing new treatments.

EDG fits into this mission by helping budding biotechnology companies take that crucial first step toward commercializing their technologies.

In 2001, it was the United Kingdom's turn to lead the pack, identified by the European Community's European Competitiveness Report as the country with the most companies in both biotechnology and bioscience - related applications.

Not only did I learn a lot more about the challenges to be faced by emerging biotechnology companies, I also met a number of people who were already involved in the area.

In recent years, escalating costs and increased global competition have led pharmaceutical and biotechnology companies to start using contractors — temporary employees who work for a contracted period of time — in jobs previously held by permanent employees.

Affinity groups are by no means unique to universities and biotechnology companies — but in these settings many of them are playing an important role in supporting diversity.

Confidence in biotechnology companies was jolted last week by the news that a major clinical trial of a drug to combat severe blood poisoning had been halted.

Another indication of how relevant the biotech industry has become here is the recent joint creation by UBC and BCIT of a bachelor of science degree in biotechnology, which includes co-op work terms with biotech companies.

The work has been done by Queensland Institute of Medical Research, the Walter and Eliza Hall Institute, Commonwealth Serum Laboratories, Biotechnology Australia, and Hoffman La Roche, the Swiss drug company.

Scientists seeking to exploit their discoveries by setting up new biotechnology companies face a difficult choice: They must either spend time learning how to run a business on a lengthy, full - time course such as an MBA, or they take the risk and plunge in at the deep end, taking advice from consultants.

A U.S. biotechnology company has found early success with a cancer drug developed by a supercomputer, BBC reports.

The Brain Trauma Indicator, developed by San Diego — based biotechnology company Banyan Biomarkers, was reviewed and authorized for commercialization in fewer than six months.

The big seed companies had no interest in these poor man's crops, but I knew that science could have an impact on our lives by solving these plant problems through breeding and biotechnology.»

The manufacturing output for the industry — which comprises pharmaceutical, medical technology, biotechnology, and health care service companies — grew by 3.2 % to a total of SG$ 6.6 billion in the year 2001.

The antibody - based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology company, is a simple, cost - effective way to determine if a person's infection is from the Zika virus or another virus of the same family, such as dengue and West Nile viruses.

To carry out this project, the CeBiTec research team cooperated with the University of Natural Resources and Life Sciences in Vienna (where the project was headed by Professor Dr. Nicole Borth), the Austrian Centre of Industrial Biotechnology (acib), and two pharmaceutical companies: Novartis (in Switzerland) and Pfizer (in the USA).

Genetically modified plants could be produced more cheaply and easily using a method announced last week by scientists from Zeneca, the British biotechnology company.

I found that out by participating in a test conducted at the Linguagen Corporation, a biotechnology company in Cranbury, New Jersey.

My laboratories at Harvard and my biotechnology companies were staffed by both brilliant young Americans and the best young minds from abroad.

The FBI is conducting an in - vestigation into international biotechnology espionage, in which the fruits of research are stolen from US biotechnology companies by foreign companies and governments.

A drug called PBT2, developed by Australian company Prana Biotechnology, appears to improve cognitive abilities in patients with early - stage Alzheimer's disease and reduce protein buildup blamed for the debilitating neurological disorder, researchers report in The Lancet Neurology.

A drug called PBT2, developed by Australian company Prana Biotechnology, appears to improve cognitive abilities in patients with early - stage Alzheimer's disease.

Thanks to a personal connection, one of the most successful biotechnology companies in the United States is apparently the new title sponsor of the Science Talent Search (STS), the prestigious high school science competitions run by the Society for Science and the Public (SSP) in Washington, D.C. New York - based Regeneron Pharmaceuticals Inc. will invest $ 100 million over the next 10 years to become the third such sponsor in STS's nearly 75 - year - long history, according to several media outlets.

The letter was written and circulated by researchers Robert Lanza and Michael West of Advanced Cell Technology, a biotechnology company in Worcester, Massachusetts.

The court upheld a lawsuit filed by Classen Immunotherapies of Baltimore, Maryland, against four biotechnology companies and a medical group, for infringing on a patent that covered the idea of trying to link infant vaccination with later immune disorders.

According to Biotechnology in Europe: 2005 Comparative Studies, a report written by Critical I Limited for EuropaBio, 60 % of the biotech companies in the United States were in the human health care sector in 2003, and 51 % in Europe.

Here's a third: Started in 2008 by the North Carolina Biotechnology Center in Research Triangle Park, the Industrial Fellowships Program places citizen or permanent - resident Ph.D. s who live, earned graduate degrees, or held postdoc appointments in the state, and who lack Ph.D. - level industrial experience, in 2 - year positions with Tarheel biotech companies.

The monoclonal antibody and Imprime PGG are investigational drugs and will be provided by Biothera, a U.S. biotechnology company.

(b) The University of California is requested to utilize California's unique collaborative research environment by convening stakeholders from public and private research institutions, national laboratories, biotechnology and high technology companies, and venture capital firms to develop the governing structure for the Cal - BRAIN program.

By partnering with companies in diverse application areas, Caribou is able to integrate discoveries from therapeutic research, agricultural biotechnology and industrial biotechnology to develop the platform further.

After receiving a master degree in Biotechnology at the University of Verona (Italy) in 1998, I joined the neuroscience centre of GlaxoSmithKline (GSK), a large research - based pharmaceutical company based in Verona (Italy) and Harlow (UK), where I pioneered the use of functional magnetic resonance imaging (MRI) to describe the neural substrates modulated by pharmacological agents, a line of research that I also pursued to obtain a PhD degree in biomedical imaging with the University of Verona.

Besides the North American seed market the company has recently opened up the Chinese and Indian markets by establishing multiple licensing and commercial product development agreements with leading Chinese and Indian seed and agricultural biotechnology companies.

CAMBRIDGE, Mass., Nov. 16, 2016 — Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced that the U.S. Patent and Trademark Office has issued two new patents related to the company's proprietary General Amyloid Interaction Motif (GAIM) platform.

The meeting was attended by over 270 registered participants from over 30 countries, e.g. Brazil, China, South Africa, United Arab Emirates, Russia, Singapore, and several European countries and supported by all major biotechnology companies, such as Agilent, Illumina, Roche Diagnostics, Life Technologies, etc..

CAMBRIDGE, Mass., Mar. 1, 2017 — Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced that Franz Hefti, Ph.D., president and chief executive officer, will present a company overview at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 1:30 p.m. ET in company developing novel therapies for diseases caused by protein misfolding, today announced that Franz Hefti, Ph.D., president and chief executive officer, will present a company overview at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 1:30 p.m. ET in company overview at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 1:30 p.m. ET in Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 1:30 p.m. ET in Boston.

Prior to ViaCyte, Robins served as Chief Scientific Officer at BresaGen, Inc., the United States subsidiary of BresaGen Limited, an Australian biotechnology company that has since been acquired by Hospira, Inc..

Cambridge, MA, September 07, 2016 — Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced that it has initiated a Phase 1b clinical trial evaluating NPT088, its lead development candidate for Alzheimer's disease.

In 2007, Dr. Villareal continued his career in neuroscience by joining Galenea Corporation, a biotechnology company located in Cambridge, Massachusetts where he focused on developing novel techniques and therapeutics to treat patients suffering with schizophrenia.

IDRI is a new kind of global health nonprofit, taking a comprehensive approach to solving infectious disease by combining the high quality science of a research organization with the product development focus and capabilities of a biotechnology company.